预测心室辅助装置支持患儿卒中:Pedimacs报告
基于Pedimacs注册2012至2022年40中心1219例19岁以下首次植入VAD患儿,分析卒中危险因素。6个月无卒中率从早期80.2%升至近期87.9%(P=.009),总体卒中率由20%降至15%,旁体搏动式装置改善最明显;参数模型识别出早期与后期卒中的不同危险因素。
要点
- 6个月无卒中率近期(2017-2023)87.9% vs 早期(2012-2016)80.2%,P=.009。
- 植入式连续流VAD 6个月无卒中率最高(91.1%),旁体连续流最低(69.5%)。
- 旁体搏动式装置早期卒中风险近期下降,风险比5.01。
核心结论
- 总体6个月卒中率从20%降至15%,旁体搏动式装置改善尤为明显。
- 危险因素分析有助于识别卒中高风险亚组并进一步优化管理。
研究设计与样本
- 回顾性多中心注册研究,Pedimacs注册2012至2022年40中心1219例19岁以下首次植入VAD患儿,共1463个装置。
- 采用多相参数风险模型识别所有装置类型卒中的危险因素。
主要发现
- 1219例患儿中最常见装置为植入式连续流(472例,39%),其次为旁体搏动式(342例,28%)和旁体连续流(327例,27%)。
- 6个月无卒中率近期(2017-2023)87.9%(95%CI 86.2%-89.4%)vs 早期(2012-2016)80.2%(95%CI 77.1%-82.9%),P=.009。
- 植入式连续流VAD 3个月无卒中率92.7%(95%CI 91.1%-93.9%)、6个月91.1%(95%CI 89.3%-92.6%);旁体搏动式分别为87.0%(95%CI 84.8%-88.9%)和82.8%(95%CI 79.8%-85.5%);旁体连续流分别为76.0%(95%CI 71.8%-79.5%)和69.5%(95%CI 63.4%-74.8%)。
- 参数模型识别出植入早期及后期卒中的危险因素;总体尤其旁体搏动式装置早期卒中风险在近期下降(风险比5.01)。
- 植入式连续流装置中心源性休克是主要危险因素;体重<10 kg患儿早期风险仅见于早期年代;先天性心脏病患儿早期风险见于非植入式装置使用和体外膜氧合使用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) provides detailed understanding on pediatric patients supported with ventricular assist devices (VADs). We sought to identify important variables affecting the incidence of stroke in pediatric VADs. METHODS: Between 2012 and 2022, 1463 devices in 1219 patients were reported to Pedimacs from 40 centers in patients aged <19 years at their first VAD implantation. Multiphase parametric hazard modeling was used to identify risk factors for stroke among all device types. RESULTS: Of the 1219 patients, the most common devices were implantable continuous (472 [39%]), followed by paracorporeal pulsatile (342 [28%]), and paracorporeal continuous (327 [27%]). Overall freedom from stroke at 6 months was higher in the recent era (2012-2016; 80.2% [95% CI, 77.1%-82.9%] vs 2017-2023; 87.9% [95% CI, 86.2%-89.4%], P = .009). Implantable continuous VADs had the highest freedom from stroke at 3 months (92.7%; 95% CI, 91.1%-93.9%) and 6 months (91.1%; 95% CI, 89.3%-92.6%), followed by paracorporeal pulsatile (87.0% [95% CI, 84.8%-88.9%] and 82.8% [95% CI, 79.8%-85.5%], respectively), and paracorporeal continuous (76.0% [95% CI, 71.8%-79.5%] and 69.5% [95% CI, 63.4%-74.8%], respectively) VADs. Parametric modeling identified risk factors for stoke early after implant and later. Overall, and particularly for paracorporeal pulsatile devices, early stroke risk has decreased in the most recent era (hazard ratio, 5.01). Among implantable continuous devices, cardiogenic shock was the major risk factor. For patients <10 kg, early hazard was only seen in the previous era. For congenital patients, early hazard was seen in nonimplantable device use and use of extracorporeal membrane oxygenation. CONCLUSIONS: The overall stroke rate has decreased from 20% to 15% at 6 months, with particular improvement among paracorporeal pulsatile devices. Risk factor analyses offer insights for identification of higher stroke risk subsets and further management refinements.
引用
- Ashfaq A, Lorts A, Rosenthal D, et al. Predicting Stroke for Pediatric Patients Supported With Ventricular Assist Devices: A Pedimacs Report. Ann Thorac Surg. 2024. PMID: 38802036. doi:10.1016/j.athoracsur.2024.05.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。